Search for: "BIOTECH, INC." Results 161 - 180 of 1,243
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 May 2018, 3:34 pm by David Jensen
”De-risking stem cell therapiesIn biotech, all this is referred often as "de-risking" and helping research advance beyond the "valley of death," the stage at which conventional financing for research becomes exceedingly difficult to secure. [read post]
26 Apr 2018, 1:00 pm by Mike Mireles
As for the future of the Silicon Valley biotech company Theranos, Inc., the company has since made hundreds of staff redundant to avert becoming insolvent.Dr J Denoncourt, Nottingham Law School [read post]
12 Feb 2018, 12:52 pm by David Jensen
It is a subsidiary of Fortress Biotech, Inc., a publicly traded, clinical‐stage biopharmaceutical company.The San Francisco Chronicle first reported the size of the payment, although the fact that a royalty check was coming was disclosed last summer. [read post]
1 Feb 2018, 5:55 pm by Kevin LaCroix
We have seen securities suits filed against mid-cap, small-cap, and even micro-cap companies, particularly in fields such as life sciences, biotech and pharma. [read post]
29 Jan 2018, 9:59 pm by Patent Docs
Janssen Biotech, Inc. and New York University ("Janssen"), co-assignees of the '471 patent, argued on appeal that obviousness-type double patenting was not applicable because the safe-harbor provision of 35 U.S.C. [read post]
10 Jan 2018, 11:57 am by David Jensen
The California stem cell agency is set to make a nearly $19 million bet next week on a treatment that is aimed at significantly improving the success of  kidney transplants and helping to reduce healthcare costs.The agency's board is expected to ratify a decision to award $18.8 million to Medeor Therapeutics, Inc. [read post]
8 Jan 2018, 8:52 am by Daily Record Staff
Gene therapy company Regenxbio Inc. of Rockville signed an agreement with AveXis Inc., a gene therapy company based in Chicago, for the development and sale of products to treat spinal muscular atrophy. [read post]
2 Jan 2018, 5:08 pm by Kevin LaCroix
The world of directors’ and officers’ liability is always dynamic, but 2017 was a particularly eventful year in the D&O liability arena. [read post]
1 Jan 2018, 9:59 pm by Kelsey M. Mackin
Maine Natural Health Inc., Warren, ME In an April 12, 2017, warning letter to company owner and CEO Harold J. [read post]
20 Dec 2017, 10:00 pm
Post By Sarah Dickhut On December 19, 2017, the Federal Circuit released an opinion in Travel Sentry, Inc. v. [read post]
1 Dec 2017, 11:35 am by Nate Nead
China’s Sanpower Group Co., Ltd. acquired Dendreon Pharmaceuticals Inc for $0.8 billion, and Sumitomo Dainippon Pharma Co., Ltd. acquired Tolero Pharmaceuticals Inc. for $0.8 billion to assist Sumitomo to refresh its pipeline.[28] In Q4 2017, a few M&A transactions have occurred in the pharma deal market. [read post]
3 Nov 2017, 7:19 am by Heather Cobun
Osiris Therapeutics Inc. did not admit or deny any of the charges in the complaint, filed Thursday in U.S. [read post]
31 Oct 2017, 9:59 pm by Patent Docs
By Donald Zuhn -- Last year, two biotech companies announced that they had received institutional review board (IRB) approval for a study focused on the clinical intervention of brain death in humans. [read post]